Biogen reaches $900m settlement to resolve kickback allegations
Biogen was alleged of paying kickbacks to health care professionals to discourage them from prescribing products of its…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jul 22
Biogen was alleged of paying kickbacks to health care professionals to discourage them from prescribing products of its…
18 Jul 22
The EC granted conditional marketing authorisation for Kinpeygo based on the efficacy and safety data from Part A…
14 Jul 22
The US FDA granted the EUA based on data from the Phase 3 PREVENT-19 clinical trial, in which…
11 Jul 22
The UK health regulator indicated Tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications, after vaccination…
06 Jul 22
The company’s claim was based on more than two decades of work on mRNA technology, which played a…
29 Jun 22
The European regulator approved Nexviadyme to treat the full spectrum of Pompe disease and Xenpozyme to treat non-Central…
29 Jun 22
Imvanex is a non-replicating smallpox vaccine that contains a live modified form of the vaccinia virus, dubbed vaccinia…
28 Jun 22
The expanded approval is based on data from the JUNIPERA trial, which showed that Cosentyx reduced the risk…
27 Jun 22
The FDA approval was based on data from the Phase 3 TRANSFORM trial and Phase 2 PILOT study,…
24 Jun 22
The vaccine has also been recommended by the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human…